On 2025-05-07, LENZ Therapeutics, Inc. (LENZ) announced earnings per share of $-0.53 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.55.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.62 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-07 | 2025-03-31 | $-0.55 | $-0.53 |
| 2025-03-19 | 2024-12-31 | $-0.42 | $-0.46 |
| 2024-11-06 | 2024-09-30 | $-0.47 | $-0.38 |
| 2024-08-14 | 2024-06-30 | $-0.49 | $-0.40 |
| 2024-05-08 | 2024-03-31 | $-0.84 | $-3.53 |
| 2023-11-13 | 2023-09-30 | $-1.75 | $-1.33 |
| 2023-08-14 | 2023-06-30 | $-2.17 | $-2.17 |
| 2023-05-11 | 2023-03-31 | $-2.10 | $-2.66 |
| 2023-03-20 | 2022-12-31 | $-3.57 | $-3.08 |
| 2022-11-09 | 2022-09-30 | $-3.43 | $-3.15 |
| 2022-08-11 | 2022-06-30 | $-3.43 | $-3.36 |
| 2022-05-12 | 2022-03-31 | $-2.52 | $-3.36 |
| 2022-03-21 | 2021-12-31 | $-1.96 | $-2.45 |
| 2021-11-10 | 2021-09-30 | $-1.96 | $-1.96 |
| 2021-08-12 | 2021-06-30 | $-7.77 | $-24.14 |